Morning Market Losers
July 10, 2014 at 09:51 AM EDT
Sarepta Therapeutics (NASDAQ: SRPT) fell 25.03% to $19.41 after the company offered long-term outcomes through 144 weeks from Phase IIb ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.